Results 141 to 150 of about 2,319 (150)

Medical control of intraocular pressure with brinzolamide 1% after phacoemulsification

Canadian Journal of Ophthalmology, 2008
Harun Cakmak
exaly  

Development of inclusion complex of brinzolamide with hydroxypropyl-β-cyclodextrin

Carbohydrate Polymers, 2013
Zhiyao He, Gu He
exaly  

The 24-Hour Effects of Brinzolamide/Brimonidine Fixed Combination and Timolol on Intraocular Pressure and Ocular Perfusion Pressure

Journal of Ocular Pharmacology and Therapeutics, 2017
Peter E Dewitt, Leonard K Seibold
exaly  

Liposomes as a Novel Ocular Delivery System for Brinzolamide: In Vitro and In Vivo Studies

AAPS PharmSciTech, 2015
Yongmei Liu, Shaohua Yao, Ke Ren
exaly  

Brimonidine and brinzolamide for treating glaucoma and ocular hypertension; a safety evaluation

Expert Opinion on Drug Safety, 2017
Ivan Goldberg
exaly  

The Efficacy and Safety of the Fixed Combination of Brinzolamide 1% and Brimonidine 0.2% in Normal Tension Glaucoma: An 18-Month Retrospective Study

Journal of Ocular Pharmacology and Therapeutics, 2018
Sang Wook Jin
exaly  

Brinzolamide–loaded nanoemulsions: ex vivo transcorneal permeation, cell viability and ocular irritation tests

Pharmaceutical Development and Technology, 2019
Ilva Rupenthal, Reza Aboofazeli, Mohammad Mehdi Mahboobian   +2 more
exaly  

Nanocarrier-based Drug Delivery of Brinzolamide for Ocular Diseases: A Mini-Review

Current Nanomedicine
Balak Das Kurmi, Preeti Patel, Rashmi Maurya   +2 more
exaly  

The intraocular pressure reducing effect of brinzolamide as adjunctive therapy to latanoprost

Current Medical Research and Opinion, 2011
exaly  

Patients' acceptance of a switch from dorzolamide to brinzolamide for the treatment of glaucoma in a clinical practice setting

Clinical Therapeutics, 2000
exaly